Takeda says COVID-19 treatment trial using recovered patients' blood could start in July

United States News News

Takeda says COVID-19 treatment trial using recovered patients' blood could start in July
United States Latest News,United States Headlines
  • 📰 ChannelNewsAsia
  • ⏱ Reading Time:
  • 34 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 17%
  • Publisher: 66%

TOKYO: Takeda Pharmaceutical could start a clinical trial as early as July for a potential treatment of COVID-19 that is based on antibodies from ...

FILE PHOTO: The logo of Takeda Pharmaceutical Co. is displayed at the company's news conference venue in Tokyo, Japan May 9, 2018. REUTERS/Kim Kyung-HoonTOKYO: Takeda Pharmaceutical could start a clinical trial as early as July for a potential treatment of COVID-19 that is based on antibodies from recovered patients' blood, company executives said on Wednesday .

The new coronavirus has infected 4.3 million people worldwide and nearly 300,000 have died, according to a Reuters tally. The pandemic has spurred several drugmakers to race to develop a viable treatment or vaccine.Takeda's proposed treatment offers a standardized dose of antibodies. It also has a much longer shelf life than unprocessed blood plasma and doesn't need to be limited to patients with matching blood types.

"It is a scarce resource," Kim said."Antibodies don't last forever and we have to capture people within that time window. This is dependant on the progression of COVID-19 within different geographies."

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

ChannelNewsAsia /  🏆 6. in SG

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Sanofi to accelerate European COVID-19 vaccine access after CEO prioritizes US preordersSanofi to accelerate European COVID-19 vaccine access after CEO prioritizes US preordersFrench drugmaker Sanofi SA said on Wednesday that it is working with European regulators to speed up access to a potential coronavirus vaccine in ...
Read more »

Sanofi to accelerate European COVID-19 vaccine accessSanofi to accelerate European COVID-19 vaccine accessNEW YORK: French drug manufacturer Sanofi SA said on Wednesday (May 13) that it is working with European regulators to speed up access to a ...
Read more »

Commentary: Airlines have it bad with COVID-19 but airports have it worseCommentary: Airlines have it bad with COVID-19 but airports have it worseHub airports like Singapore’s Changi Airport and Dubai International Airport, in particular, may not recover that quickly, says Nitin Pangarkar.
Read more »

Commentary: India’s fragmented healthcare system is its Achilles’ heel in the fight against COVID-19Commentary: India’s fragmented healthcare system is its Achilles’ heel in the fight against COVID-19The inequities in availability, accessibility, affordability and quality of health services in the public and private sectors have been apparent ...
Read more »

US governors call for less partisanship, more aid to fight COVID-19US governors call for less partisanship, more aid to fight COVID-19WASHINGTON: Governors from both major political parties on Wednesday (May 13) urged lawmakers in Washington, D.C., to cast aside partisanship and ...
Read more »



Render Time: 2025-03-12 09:47:53